These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25657794)

  • 1. Development and optimization of buspirone oral osmotic pump tablet.
    Derakhshandeh K; Berenji MG
    Res Pharm Sci; 2014; 9(4):233-41. PubMed ID: 25657794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation design and characterization of an elementary osmotic pump tablet of flurbiprofen.
    Patel KN; Mehta TA
    PDA J Pharm Sci Technol; 2014; 68(4):333-46. PubMed ID: 25035256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Swellable elementary osmotic pump (SEOP): an effective device for delivery of poorly water-soluble drugs.
    Shokri J; Ahmadi P; Rashidi P; Shahsavari M; Rajabi-Siahboomi A; Nokhodchi A
    Eur J Pharm Biopharm; 2008 Feb; 68(2):289-97. PubMed ID: 17616378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development, evaluation, and influence of formulation and process variables on
    Arjun N; Narendar D; Sunitha K; Harika K; Nagaraj B
    Int J Pharm Investig; 2016; 6(4):238-246. PubMed ID: 28123994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an osmotic pump system for controlled delivery of diclofenac sodium.
    Emara LH; Taha NF; Badr RM; Mursi NM
    Drug Discov Ther; 2012 Oct; 6(5):269-77. PubMed ID: 23229148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of controlled release osmotic pump tablet of glipizide solid dispersion.
    Patel GC; Asodaria KV; Patel HP; Shah DR
    Curr Drug Deliv; 2014; 11(6):817-27. PubMed ID: 23859357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled porosity osmotic pump-based controlled release systems of pseudoephedrine. I. Cellulose acetate as a semipermeable membrane.
    Makhija SN; Vavia PR
    J Control Release; 2003 Apr; 89(1):5-18. PubMed ID: 12695059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microporous bilayer osmotic tablet for colon-specific delivery.
    Chaudhary A; Tiwari N; Jain V; Singh R
    Eur J Pharm Biopharm; 2011 May; 78(1):134-40. PubMed ID: 21255646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and evaluation of microporous osmotic tablets of diltiazem hydrochloride.
    Bathool A; Gowda DV; Khan MS; Ahmed A; Vasudha SL; Rohitash K
    J Adv Pharm Technol Res; 2012 Apr; 3(2):124-9. PubMed ID: 22837961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.
    Lin HL; Lin SY; Lin YK; Ho HO; Lo YW; Sheu MT
    Eur J Pharm Biopharm; 2008 Sep; 70(1):289-301. PubMed ID: 18539015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and evaluation of controlled porosity osmotic pump for oral delivery of ketorolac.
    Dasankoppa FS; Ningangowdar M; Sholapur H
    J Basic Clin Pharm; 2012 Dec; 4(1):2-9. PubMed ID: 24808662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasticizer effect and comparative evaluation of cellulose acetate and ethylcellulose-HPMC combination coatings as semipermeable membranes for oral osmotic pumps of naproxen sodium.
    Ramakrishna N; Mishra B
    Drug Dev Ind Pharm; 2002 Apr; 28(4):403-12. PubMed ID: 12056533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monolithic osmotic tablet system for nifedipine delivery.
    Liu L; Khang G; Rhee JM; Lee HB
    J Control Release; 2000 Jul; 67(2-3):309-22. PubMed ID: 10825563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: screening of formulation variables and in vitro investigation.
    Liu H; Yang XG; Nie SF; Wei LL; Zhou LL; Liu H; Tang R; Pan WS
    Int J Pharm; 2007 Mar; 332(1-2):115-24. PubMed ID: 17052871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and optimization of porous osmotic pump-based controlled release system of oxybutynin.
    Kanagale P; Lohray BB; Misra A; Davadra P; Kini R
    AAPS PharmSciTech; 2007 Jul; 8(3):E53. PubMed ID: 17915803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting the release of nifedipine from a swellable elementary osmotic pump.
    Nokhodchi A; Momin MN; Shokri J; Shahsavari M; Rashidi PA
    Drug Deliv; 2008 Jan; 15(1):43-8. PubMed ID: 18197523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality by Design (QbD)-Based Numerical and Graphical Optimization Technique for the Development of Osmotic Pump Controlled-Release Metoclopramide HCl Tablets.
    Farooqi S; Yousuf RI; Shoaib MH; Ahmed K; Ansar S; Husain T
    Drug Des Devel Ther; 2020; 14():5217-5234. PubMed ID: 33273807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of bilayer-core osmotic pump tablet by coating the indented core tablet.
    Liu L; Xu X
    Int J Pharm; 2008 Mar; 352(1-2):225-30. PubMed ID: 18068918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and development of controlled porosity osmotic tablet of diltiazem hydrochloride.
    Shahi SR; Zadbuke NS; Gulecha B; Shivanikar SS; Shinde SB
    J Adv Pharm Technol Res; 2012 Oct; 3(4):229-36. PubMed ID: 23378944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preparation of ondansetron hydrochloride osmotic pump tablets and their in vitro drug release].
    Zheng HS; Bi DZ
    Yao Xue Xue Bao; 2005 Dec; 40(12):1080-4. PubMed ID: 16496669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.